Literature DB >> 21115730

HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.

Palanee Ammaranond1, David J van Bockel, Kathy Petoumenos, Marylin McMurchie, Robert Finlayson, Melanie G Middleton, Miles P Davenport, Vanessa Venturi, Kazuo Suzuki, Linda Gelgor, John M Kaldor, David A Cooper, Anthony D Kelleher.   

Abstract

The CTL response in HLA-B*27(+) HIV-infected individuals is characterized by an immunodominant response to a conserved epitope in gag p24 (aa 263-272, KRWIILGLNK; KK10). Mutations resulting in substitution of the arginine (R264) at position 2 of this epitope have been identified as escape mutations. Nineteen HLA-B*27(+) long-term nonprogressors were identified from an Australian cohort with an average follow-up of 16 y following infection. Viral and host genetic factors impacting on disease progression were determined at multiple time points. Twelve of 19 had wild-type sequences at codon 264 at all time points; 7 of 19 carried CTL escape variants. Median viral load and CD4(+) T cell counts were not significantly different between these groups at enrollment. Viral load, as judged by levels at their last visit (1,700 and 21,000 RNA copies/ml, respectively; p = 0.01) or by time-weighted area under the curve was higher in the escape group (p = 0.02). Escape mutants at other HLA-B*27-restricted epitopes were uncommon. Moreover, host polymorphisms, such as CCR5Δ32, CCR2-64I, and SDF1-3'A, or breadth of TCR repertoire responding to KK10 did not segregate to wild-type or escape groups. Host and viral factors were examined for a relationship to viral load. The only factor to affect viral load was the presence of the R264 escape mutations at the immunodominant epitope. CTL escape at R264 in the KK10 epitope is a major determinant of subsequent viral load in these HLA-B*27(+) individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115730     DOI: 10.4049/jimmunol.0903227

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  HIV and HLA class I: an evolving relationship.

Authors:  Philip J R Goulder; Bruce D Walker
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

2.  HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes.

Authors:  Florencia Pereyra; David Heckerman; Jonathan M Carlson; Carl Kadie; Damien Z Soghoian; Daniel Karel; Ariel Goldenthal; Oliver B Davis; Charles E DeZiel; Tienho Lin; Jian Peng; Alicja Piechocka; Mary Carrington; Bruce D Walker
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

3.  High polymorphism rates in well-known T cell epitopes restricted by protective HLA alleles during HIV infection are associated with rapid disease progression in early-infected MSM in China.

Authors:  Chuan He; Xiaoxu Han; Hui Zhang; Fanming Jiang; Minghui An; Bin Zhao; Haibo Ding; Zining Zhang; Tao Dong; Hong Shang
Journal:  Med Microbiol Immunol       Date:  2019-03-08       Impact factor: 3.402

4.  Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.

Authors:  Hayato Murakoshi; Madoka Koyanagi; Takayuki Chikata; Mohammad Arif Rahman; Nozomi Kuse; Keiko Sakai; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1.

Authors:  Xiaoman Li; Wei Xu; Sidong Xiong
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

6.  HIV-1 mutants that escape the cytotoxic T-lymphocytes are defective in viral DNA integration.

Authors:  Muthukumar Balasubramaniam; Benem-Orom Davids; Alex Bryer; Chaoyi Xu; Santosh Thapa; Jiong Shi; Christopher Aiken; Jui Pandhare; Juan R Perilla; Chandravanu Dash
Journal:  PNAS Nexus       Date:  2022-05-20

7.  Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins.

Authors:  Christian L Boutwell; Jonathan M Carlson; Tien-Ho Lin; Aaron Seese; Karen A Power; Jian Peng; Yanhua Tang; Zabrina L Brumme; David Heckerman; Arne Schneidewind; Todd M Allen
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

8.  Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication.

Authors:  Justine Sunshine; Moon Kim; Jonathan M Carlson; David Heckerman; Julie Czartoski; Stephen A Migueles; Janine Maenza; M Juliana McElrath; James I Mullins; Nicole Frahm
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

9.  Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa.

Authors:  Romel D Mackelprang; Mary Carrington; Katherine K Thomas; James P Hughes; Jared M Baeten; Anna Wald; Carey Farquhar; Kenneth Fife; Mary S Campbell; Saida Kapiga; Xiaojiang Gao; James I Mullins; Jairam R Lingappa
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

10.  Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.

Authors:  John Zaunders; David van Bockel
Journal:  Front Immunol       Date:  2013-04-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.